Klein Lawrence Otto
SEC CIK 1762583 · EDGAR
BoughtSold
Most active insiders at ORKA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| 2 | Dambkowski Carl | Dir | — | $8.65M |
| 3 | Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| 4 | Quinlan Paul T | GC | — | $6.76M |
| 5 | Goncalves Joana | Chief Medical Off | — | $4.54M |
| 6 | Agarwal Arjun | SVP, Fin | — | $4.33M |
| 7 | Sandler Laura Lee | COO | — | $1.94M |
| 8 | Edwards Larry Todd | Chief Commercial Off | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 19:15 | 2026-09-15 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | CEO, Dir | S - Sale | $95.71 | -2,452 | 923.1K | -0.3% | -$234.7K | |
| DT | 2026-09-01 18:35 | 2026-09-01 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | CEO, Dir | M - OptEx | $7.80 | +75.0K | 1.00M | +8% | +$585.0K |
| DMT | 2026-09-01 18:35 | 2026-09-01 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | CEO, Dir | S - Sale+OE | $91.83 | -75.0K | 925.6K | -7% | -$6.89M |
| 2026-06-15 18:52 | 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | CEO, Dir | S - Sale | $69.69 | -1,729 | 925.6K | -0.2% | -$120.5K | |
| 2026-03-17 | 2026-03-16 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | CEO, Dir | S - Sale | $41.30 | -1,729 | 927.3K | -0.2% | -$71.4K | |
| D | 2026-01-23 | 2026-01-23 | ORKA | Oruka Therapeutics, Inc. | Klein Lawrence Otto | CEO, Dir | A - Grant | $0.00 | +76.7K | 929.0K | +9% | $0 |
| 2022-10-13 | 2022-10-12 | JSPR | Jasper Therapeutics, Inc. | Klein Lawrence Otto | Dir | A - Grant | $0.00 | +24.5K | 24.5K | New | $0 | |
| DM | 2022-03-14 | 2022-03-10+ | CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | COO, CBO | M - OptEx | — | +7,584 | 26.9K | +39% | — |
| DM | 2022-03-14 | 2022-03-11+ | CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | COO, CBO | F - Tax | $61.98 | -3,112 | 25.0K | -11% | -$192.9K |
| D | 2021-12-07 | 2021-12-03 | CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | COO, CBO | M - OptEx | — | +26.7K | 33.5K | +390% | — |
| D | 2021-12-07 | 2021-12-06 | CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | COO, CBO | F - Tax | $69.17 | -11.2K | 22.3K | -33% | -$773.7K |
| D | 2021-09-14 | 2021-09-13 | CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | COO, CBO | F - Tax | $117.86 | -4,207 | 6,843 | -38% | -$495.8K |
| D | 2021-09-14 | 2021-09-10 | CRSP | CRISPR Therapeutics AG | Klein Lawrence Otto | COO, CBO | M - OptEx | — | +10.0K | 11.1K | +952% | — |
Purchase Sale Sale after option exercise All abbreviations